MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case-control study and meta-analysis.
Several studies have investigated whether MTHFR rs1801133 polymorphism contributes to risk of colorectal cancer (CRC), however the results are inconclusive. The purpose of this study was to investigate this hypothesis in a case-control study and meta-analysis in Iranian population. This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC. Both case-control study and meta-analysis showed no association between rs1801133 and CRC risk or its features. This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.